Skip to content

A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation

Use of Aerosol Box for Ultrasound-guided Internal Jugular Vein Cannulation in COVID-19 Patients; Single Center Experience

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04954118
Enrollment
40
Registered
2021-07-08
Start date
2020-03-20
Completion date
2020-09-30
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pneumonia

Keywords

Aerosol box, SARS-CoV-2 virus, COVID-19, Internal jugular vein, Personal protective equipment

Brief summary

During the COVID-19 pandemic, health employees are at high risk of infection. This study aimed to determine experiences with an aerosol box (AB), used with the aim of preventing contamination by droplets during internal jugular vein cannulation which requires close contact with COVID-19 patients, and the necessity to use this device.

Detailed description

The study included 40 patients with diagnosis of COVID-19 requiring central venous catheter during treatment in the ward. The patients were randomly allocated to one of the two protective equipment groups and, then, randomly assigned to one of the five clinicians. Group P&A had both personal protective equipment (PPE) and AB used, while Group P included patients where PPE was used alone. Clinicians completed a survey after performing the procedure to evaluate the use of the aerosol box. Collected data of the procedures and patients, were analyzed. In addition, survey data were evaluated.

Interventions

The clinicians performed an internal jugular vein cannulation using personal protective equipment (PPE) or both of the aerosol box and PPE provide insertion of a central venous catheter in COVID-19 patients.

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with COVID-19 and inserted central venous catheter while being treated in the ward

Exclusion criteria

* Patients under the age of 18 years * Patients who can not lie in the supine position due to severe respiratory distress, * Patients with thrombus in the right İJV in evaluation with US

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire on the Use of Aerosol Boxes7 months from the index case of the pandemic in TurkeyThere is no valid and reliable questionnaire in the literature that evaluates behaviors and attitudes towards aerosol box use. Therefore, in our study, a questionnaire was conducted about the attitudes and behaviors of the participants towards aerosol box preservatives.There are 6 statements in the content of the questionnaire on aerosol box use. The questionnaire consists of expressions such as 1-Discomfort using box, 2-Difficulty in manipulation during the performance, 3-Difficulty in use of US device restricted by box, 4-Increased cognitive load from use of box, 5-Increased physical load from use of box, 6-User satisfaction respectively. Participants were asked to answer these statements as ''yes or no''. According to the response received, positive or negative attitudes towards the use of aerosol boxes were evaluated.
Catheter-related infection after central venouse catheterization in COVID-197 months from the index case of the pandemic in TurkeyWhen the body temperature of the patients is above 38, blood, urine and if the patient is intubated, a tracheal aspirate culture will be taken. If the blood culture test is a positive, a diagnosis of catheter-related infection will be made and central venouse catheter will be removed.

Secondary

MeasureTime frameDescription
Number of arterial punctures7 months from the index case of the pandemic in TurkeyThe difference in the number of arterial punctures developed during central venous catheterization in patients with or without aerosol box.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026